Compositions to suppress gastric bleeding in indomethacin and phenylbutazone therapy
US3993767A · kind A · utility
4Cited by
0References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 18, 1975 |
| Grant date | Nov 23, 1976 |
| Priority date | — |
| Expiry date | Nov 18, 1995 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/42
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of treating symptomatic conditions of inflammation due to chronic and acute rheumatic and degenerative joint disease with a combination of indomethacin or phenylbutazone and a phenoxymethyl-2-oxazolidinone resulting in beneficial reduction in side effects of ulceration and bleeding in the lower intestinal tract normally associated with indomethacin and phenylbutazone and compositions containing the combination are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.